Taro Expands Branded Over-the-Counter Portfolio in U.S. with the Launch of FeverAll® Liquid Oral Acetaminophen for Children Ages 2-11 [Yahoo! Finance]
Taro Pharmaceutical Industries Ltd. Ordinary Shares (TARO)
Last taro pharmaceutical industries ltd. ordinary shares earnings: 2/3 05:21 pm
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=114698&p=irol-irhome
Company Research
Source: Yahoo! Finance
HAWTHORNE, N.Y. March 6, 2024 /PRNewswire-PRWeb/ -- Taro Pharmaceuticals U.S.A. , Inc., a subsidiary of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), today announced the expansion of its growing FeverAll® children's fever brand with a new liquid oral acetaminophen suspension format. New FeverAll® Children's Liquid Oral Acetaminophen, available in cherry and grape flavors, complements the brand's current offerings, which include three dosing levels of the doctor-recommended FeverAll® Acetaminophen Suppositories. The new liquid, which comes with a child-designed 15ml dosing cup, offers parents an additional option for the temporary relief of pain and fever in children aged two to 11, while the popular 80 mg suppository can be utilized in children as young as six months' of age. "Our extension of the FeverAll® product line is a direct result of consumers' increasing demand for additional FeverAll® products and the need to provide parents with this option on shelves during the cold
Show less
Read more
Impact Snapshot
Event Time:
TARO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TARO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TARO alerts
High impacting Taro Pharmaceutical Industries Ltd. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
TARO
News
- TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TAROBusiness Wire
- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.MarketBeat
- Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd. [Yahoo! Finance]Yahoo! Finance
- Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.Business Wire
- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.MarketBeat
TARO
Earnings
- 1/25/24 - Beat
TARO
Sec Filings
- 4/15/24 - Form SC
- 3/20/24 - Form SC
- 3/11/24 - Form SC
- TARO's page on the SEC website